Lynn M. Schuchter elected ASCO president for 2023-2024; seven members elected to ASCO board of directors and nominating committee

ASCO 2024 special awards go to: Winn, Bhatia, Dale, Siu, Pierce, Kantoff, Newman, Gopal, Mutebi, Feldman, Gorlick, Pietenpol, Abrahm, Giordano, Vaz-Luis

ASCO and Conquer Cancer, the ASCO Foundation, will recognize researchers, patient advocates, philanthropists, teachers, and global oncology leaders at the 2024 ASCO Annual Meeting.

March 22, 2024

Vol.50 No.12

Clinical Roundup

ASCO calls for global equity in cancer clinical trials

In a policy statement, the American Society of Clinical Oncology calls for global equity in clinical trials.

March 15, 2024

Vol.50 No.11

In Brief

Pamela Kunz named editor-in-chief of new JCO Oncology Advances

Pamela Kunz was named editor-in-chief of JCO Oncology Advances, a new open-access journal published by The American Society of Clinical Oncology.

February 02, 2024

Vol.50 No.05

In Brief

ASCO expresses support for CMS rule establishing electronic prior authorization in federal health plans

The Centers for Medicare & Medicaid Services issued its rule requiring federal health plans—including Medicare Advantage plans, Medicaid plans, and Qualified Health Plans on Federally Facilitated Exchanges—to establish an electronic prior authorization process that will be integrated into providers’ workflows.

January 19, 2024

Vol.50 No.03

Clinical Roundup

ASCO calls for expansion of access to clinical trials

A paper authored by members of an American Society of Clinical Oncology Task Force illuminates the importance of enabling patients to receive trial-related testing and care near their homes, rather than requiring patients to travel long distances to reach major research institutions.

January 12, 2024

Vol.50 No.02